All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up ...
BofA raised the firm’s price target on Amgen (AMGN) to $275 from $256 and keeps an Underperform rating on the shares. Q4 results were slightly ...
Erste Group analyst Hans Engel upgraded Amgen (AMGN) to Buy from Hold. Amgen has a higher operating margin and a higher return on equity than ...
Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...
Earnings season continues, with a diverse array of companies set to unveil their financial results for the next trading day. Investors are gearing up for a busy Tuesday as tech giants, pharmaceutical ...
Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...